As Brexit looms, UK pitches new industry plan, wins support from Merck, Qiagen Mon, 27 Nov 2017 08:56:55 +0000 Britain pitched a new strategy for industry on Monday that sees greater state intervention to tackle weak productivity and to help the world's sixth largest economy cope with the upheaval of leaving the European Union. Prime Minister Theresa May first flagged the plan in January, seven months after Britain voted to leave the European Union, adopting a hands-on approach to business that had largely been abandoned by her predecessors from the time of Margaret Thatcher in the 1980s. The government said it had secured major investments from global healthcare company MSD, known as Merck & Co in the United States, and German-based diagnostics company Qiagen ahead of the publication of the strategy.
UK launches plan for industry as Brexit looms, wins Merck investment Mon, 27 Nov 2017 00:01:00 +0000 The British government launched a new strategy for industry on Monday, aiming to intervene in key sectors to tackle weak productivity and bolster businesses to counter any new problems caused by Brexit. Prime Minister Theresa May first flagged the plan in January, seven months after Britain voted to leave the European Union, adopting a hands-on approach to business that had largely been abandoned by her predecessors from the time of Margaret Thatcher in the 1980s. Business Minister Greg Clark said Britain has some of the world's best universities and research institutions, as well as leading companies in sectors ranging from advanced manufacturing to financial services, life sciences and creative industries.
U.K. Seeks to Take Sting Out of Brexit With Industrial Strategy Mon, 27 Nov 2017 00:01:00 +0000 Business Secretary Greg Clark said reviving Britain’s flagging productivity lies at the heart of the industrial strategy he’ll unveil on Monday to help chart the future of Britain’s economy as the country ...
3 Companies Competing to Gain Lead in Ovarian Cancer Market Fri, 24 Nov 2017 16:24:04 +0000 Three companies including a major pharma player are developing drugs for the treatment of ovarian cancer using a new technology instead of chemotherapy and competing to gain market share.
52-Week Company Lows Fri, 24 Nov 2017 15:44:46 +0000 Details the 52-week lows of the following companies: General Electric, Merck & Co., Schlumberger, Kinder Morgan, Williams Companies and Archer-Daniels Midland
Top 10 Largest Pharmaceutical Companies By Revenue in 2017 Thu, 23 Nov 2017 14:00:14 +0000 The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced manufacturing and R&D facilities. Though their businesses are recession-proof, a huge portion of their expenses has to be allocated to research and development to stay ahead of the competition. Medicine has […]
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 0.62 (median winner: 1.53)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.